Owing to the importance of in vitro screening and target validation during the early stages of antibody discovery, Sino Biological has established in vitro activity assay platforms for streamlining antibody drug development projects.
A new Oxera report has found that the NHS benefits by up to £571 million annually in bowel cancer care alone thanks to biomedical scientists, active in 95% of patient pathways
Instruments from Agilent Technologies recognized as having made an impact on laboratory sustainability
Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%
Uniting executives from across the pharmaceutical industry to provide insights into accelerated drug discovery and clinical research through artificial-intelligence.
How can a proteomics platform that can measure over 7,000 protein biomarkers from one sample be used to assess an individual’s overall health, monitor disease progression, and inform healthcare decisions?
Learn about the spectroscopic methods used by Dr. Fiona Brock in collaboration with Historic England
The seamless integration of AI into digital pathology workflows aims to improve quality and efficiency of cancer diagnosis
Company also receives new FDA emergency use authorizations for use of self-collection molecular diagnostic kit on the Hologic and Roche platforms
Platinum®, Quantum-Si’s innovative protein sequencing platform, could bring affordable, benchtop protein sequencing with automated analysis to every lab
